CCR5 and cancer: During the study of the CCL5/CCR5 axis in cancer, the main focus was on targeting the interaction through the inhibition of CCR5 with antagonists, with the inhibition of CCL5 expression with neutralizing antibodies or gene silencing and generation of CCL5-knockout mice.